Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study

Data regarding the effect of orthotopic liver transplantation (OLT) for primary sclerosing cholangitis (PSC) on inflammatory bowel disease (IBD) course are scarce and conflicting. To compare the incidence of refractory IBD in two groups (OLT and non-OLT) of patients affected by IBD and PSC. An obser...

Full description

Saved in:
Bibliographic Details
Published in:Digestive and liver disease 2021-06, Vol.53 (6), p.712-716
Main Authors: Ribaldone, Davide Giuseppe, Imperatore, Nicola, Le Grazie, Marco, Furfaro, Federica, Balestrieri, Paola, De Blasio, Federico, Fagoonee, Sharmila, Mosso, Elena, Boano, Valentina, Reggio, Dario, Sarli, Ennio, Castiglione, Fabiana, Milla, Monica, Vecchi, Maurizio, Saracco, Giorgio Maria, Salizzoni, Mauro, Romagnoli, Renato, Fiorino, Gionata, Astegiano, Marco
Format: Article
Language:English
Subjects:
Adult
Cholangitis, Sclerosing - complications
Cholangitis, Sclerosing - surgery
Disease Progression
Female
Humans
Inflammatory Bowel Diseases - complications
Inflammatory Bowel Diseases - physiopathology
Italy
Kaplan-Meier Estimate
Liver Transplantation - adverse effects
Male
Middle Aged
OLT
Orthotopic liver transplantation
Primary sclerosing cholangitis
PSC
Retrospective Studies
Risk Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Data regarding the effect of orthotopic liver transplantation (OLT) for primary sclerosing cholangitis (PSC) on inflammatory bowel disease (IBD) course are scarce and conflicting. To compare the incidence of refractory IBD in two groups (OLT and non-OLT) of patients affected by IBD and PSC. An observational, multicentre, cohort retrospective study was conducted by the Italian Group for the study of IBD in Italy. The primary outcome was the need for biologic therapy or bowel resection for medically refractory IBD or hospitalization due to IBD relapse during the follow-up. Secondary outcomes were rate of colonic dysplasia, colorectal cancer, other solid tumours, lymphoma. Eighty-four patients were included in the study. The primary outcome was not different between OLT and non-OLT groups (11/27, 40.7%, versus 20/57, 35.1%, respectively, p = 0.62). The lymphoma and other tumours (thyroid cancer, kidney cancer, ileal tumour, ovarian cancer, cervical cancer) rates were significantly higher in the OLT group (p = 0.04 and p = 0.005, respectively), at the limit of statistical significance for high-grade colonic dysplasia (p = 0.06). OLT in patients affected by IBD and PSC is not a risk factor for a more severe IBD course, but it is associated with a higher occurrence of cancer.
ISSN:1590-8658
1878-3562
DOI:10.1016/j.dld.2020.09.011